Keyphrases
αB-crystallin
100%
Novel Biomarkers
100%
Breast Cancer
100%
Breast Cancer Patients
44%
Chemotherapy Response
33%
Prognostic Factors
33%
Poor Survival
22%
Human Epidermal Growth Factor Receptor 2 (HER2)
22%
Taxanes
22%
Clinical Value
22%
Prognostic Marker
22%
Adjuvant Chemotherapy
11%
Lymph Node Status
11%
Estrogen Receptor
11%
Characteristic Response
11%
Size Grading
11%
Estrogen Receptor-negative
11%
Tumor Chemotherapy
11%
Taxol
11%
Lymph Node Positive
11%
Neoadjuvant Chemotherapy Response
11%
Neoadjuvant
11%
Survival Response
11%
Tumor Survival
11%
Basal-like
11%
Tissue Microarray
11%
Patient-independent
11%
Clinical Guide
11%
Tumor Grade
11%
Axillary Lymph Node Metastasis
11%
Oncogenic Proteins
11%
NSABP
11%
Univariate Analysis
11%
Tumor Size
11%
Small Heat Shock Protein (sHSP)
11%
ErbB2
11%
Clinical Index
11%
Chemotherapy Agents
11%
Overexpression
11%
Multivariate Analysis
11%
Clinical Outcomes
11%
Apoptosis
11%
Northwestern University
11%
Chemotherapy Drugs
11%
Causes of Mortality
11%
Patient-specific
11%
Chemotherapy
11%
Chemotherapy Treatment
11%
Patient-specific Therapy
11%
Clinical Trials
11%
Doxorubicin
11%
Tumor
11%
Breast Tumor
11%
Immunohistochemistry
11%
Tumor Biomarkers
11%
Breast Cancer Cells
11%
Tumor Characteristics
11%
Medicine and Dentistry
Breast Cancer
100%
Biological Marker
100%
Crystallin
100%
Neoplasm
44%
Chemotherapy
27%
Lymph Node
22%
Estrogen Receptor
22%
Chemotherapy Agent
11%
Small Heat Shock Protein
11%
Breast Tumor
11%
Programmed Cell Death
11%
Tumor Marker
11%
Tissue Microarray
11%
Axillary Lymph Node
11%
Lymph Node Metastasis
11%
Cancer Cell
11%
Prognostic Factor
11%
Adjuvant Chemotherapy
11%
Neoadjuvant Chemotherapy
11%
Malignant Neoplasm
11%
Immunohistochemistry
11%
Univariate Analysis
11%
Clinical Trial
11%
Multivariate Analysis
11%
Doxorubicin
11%
Paclitaxel
11%
Nursing and Health Professions
Crystallin
100%
Biological Marker
100%
Breast Cancer
100%
Neoplasm
33%
Estrogen Receptor
22%
Adjuvant Chemotherapy
11%
Lymph Node Metastasis
11%
Small Heat Shock Protein
11%
Neoadjuvant Chemotherapy
11%
Breast Tumor
11%
Univariate Analysis
11%
Tumor Volume
11%
Clinical Outcome
11%
Doxil
11%
Malignant Neoplasm
11%
Tissue Microarray
11%
Tumor Marker
11%
Paclitaxel
11%
Multivariate Analysis
11%
Immunohistochemistry
11%